Literature DB >> 26886121

Management of Primary Angle-Closure Glaucoma.

Jimmy Lai1, Bonnie N K Choy, Jennifer W H Shum.   

Abstract

Primary angle-closure glaucoma (PACG) is a progressive optic nerve degeneration and is defined as a glaucomatous optic neuropathy with associated characteristic enlargement of optic disc cupping and visual field loss that is secondary to ocular hypertension caused by closure of the drainage angle. Angle closure is caused by appositional approximation or adhesion between the iris and the trabecular meshwork. The main treatment strategy for PACG lies in the reduction of intraocular pressure, reopening of the closed angle, and possible prevention of further angle closure. There is no universally agreed best surgical treatment for PACG. Trabeculectomy, goniosynechialysis (GSL), glaucoma implant, and cyclodestructive procedures are effective surgical options. Each of them plays an important role in the management of PACG with its own pros and cons. Accumulating evidence is available to show the effectiveness of visually significant and visually nonsignificant cataract extraction in the treatment of PACG. Trabeculectomy and GSL are often combined with cataract extraction, which may offer additional pressure control benefits to patients with PACG. This review article will discuss laser peripheral iridotomy, argon laser peripheral iridoplasty, and surgeries such as GSL, phacoemulsification, and phaco plus glaucoma surgeries that lower intraocular pressure and also alter the anterior segment and/or drainage angle anatomy. Currently, glaucoma implants and cyclodestruction are mainly reserved for PACG patients who have failed previous filtering operations. Their role as initial surgical treatment for PACG will not be discussed.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26886121     DOI: 10.1097/APO.0000000000000180

Source DB:  PubMed          Journal:  Asia Pac J Ophthalmol (Phila)        ISSN: 2162-0989


  9 in total

1.  Clear Lens Extraction for Early Angle-Closure Glaucoma: Revolution or Overtreatment?

Authors:  Ke Shi; Zhipeng You; Changyun Wang
Journal:  Med Princ Pract       Date:  2017-03-16       Impact factor: 1.927

2.  HSP70 expression before and after treatment and its clinical value in patients with acute angle-closure glaucoma.

Authors:  Hong Chen; Aijun Tian; Yixiang Wu; Rongrong Li; Ruijuan Han; Xiaowei Xu; Sumian Cheng
Journal:  Exp Ther Med       Date:  2021-01-25       Impact factor: 2.447

3.  Efficacy and safety of trabeculectomy versus peripheral iridectomy plus goniotomy in advanced primary angle-closure glaucoma: study protocol for a multicentre, non-inferiority, randomised controlled trial (the TVG study).

Authors:  Xinbo Gao; Aiguo Lv; Fengbin Lin; Ping Lu; Yi Zhang; Wulian Song; Xiaomin Zhu; Hengli Zhang; Mengfei Liao; Yunhe Song; Kun Hu; Yingzhe Zhang; Yuying Peng; Li Tang; Huiping Yuan; Lin Xie; Guangxian Tang; Xin Nie; Ling Jin; Sujie Fan; Xiulan Zhang
Journal:  BMJ Open       Date:  2022-07-04       Impact factor: 3.006

4.  Effect of intraocular lens implantation on visual field in glaucoma and comorbid cataracts.

Authors:  Can Zhao; Qing Cun; Yi-Jin Tao; Wen-Yan Yang; Hua Zhong; Feng-Jie Li; Sean Tighe; Ying-Ting Zhu; Ting Wang
Journal:  Int J Ophthalmol       Date:  2020-04-18       Impact factor: 1.779

5.  Combined Phacoemulsification and Goniosynechialysis under an Endoscope for Chronic Primary Angle-Closure Glaucoma.

Authors:  Li Nie; Weihua Pan; Aiwu Fang; Zhangliang Li; Zhenbin Qian; Lin Fu; Yau Kei Chan
Journal:  J Ophthalmol       Date:  2018-02-08       Impact factor: 1.909

6.  Twelve-month outcomes of excisional goniotomy using the Kahook Dual Blade® in eyes with angle-closure glaucoma.

Authors:  Syril Dorairaj; Mai Dang Tam; Goundappa K Balasubramani
Journal:  Clin Ophthalmol       Date:  2019-09-10

7.  Efficacy and safety of phacotrabeculectomy versus phacogoniotomy in advanced primary angle-closure glaucoma: study protocol for a multicentre non-inferiority randomised controlled trial (PVP Study).

Authors:  Yunhe Song; Wulian Song; Yi Zhang; Hengli Zhang; Meichun Xiao; Xiaohuan Zhao; Aiguo Lv; Xiaowei Yan; Ping Lu; Xiaomin Zhu; Xinbo Gao; Kun Hu; Yingzhe Zhang; Xiaohong Liang; Xi Zhang; Guangxian Tang; Lan Lu; Minwen Zhou; Sujie Fan; Lin Xie; Ling Jin; Li Tang; Huiping Yuan; Xiulan Zhang
Journal:  BMJ Open       Date:  2021-12-08       Impact factor: 2.692

Review 8.  Utilization of Modified Induced Pluripotent Stem Cells as the Advance Therapy of Glaucoma: A Systematic Review.

Authors:  Diondra Eka Rizkiawan; Malinda Evelyn; Kevin Christian Tjandra; Budi Setiawan
Journal:  Clin Ophthalmol       Date:  2022-08-29

9.  Real-world Surgical Outcomes of Primary Angle-closure Glaucoma.

Authors:  Boonsong Wanichwecharungruang; Chompunoot Phumratprapin; Kittipong Kongsomboon; Kasem Seresirikachorn
Journal:  Clin Ophthalmol       Date:  2021-06-29
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.